Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.

Area of Science:

• Hematology
• Molecular Biology
• Developmental Biology

Background:

• Hematopoietic stem cells (HSCs) are crucial for blood development.
• Transcription factor GATA-2 is essential for hematopoiesis, and its mutations are linked to leukemia.
• GATA-2 expression is regulated by specific enhancers controlling HSC generation and progenitor differentiation.

Purpose of the Study:

• To elucidate the distinct roles of the +9.5-kb and -77-kb GATA-2 enhancers in hematopoietic stem cell (HSC) and progenitor development.
• To investigate whether the +9.5-kb enhancer functions in progenitors or if GATA-2 expression in progenitors relies solely on the -77-kb enhancer.

Main Methods:

• Utilized compound heterozygous (CH) mice with deletions in both -77-kb and +9.5-kb GATA-2 enhancers.
• Analyzed HSC generation, megakaryocyte-erythroid progenitor (MEP) populations, and GATA-2 target gene expression in mutant embryos.
• Investigated the role of the -77-kb enhancer in inducing specific erythroid progenitors.

Main Results:

• The +9.5-kb enhancer is sufficient for HSC generation, but both -77-kb and +9.5-kb enhancers on the same allele are required for megakaryocyte-erythroid progenitor (MEP) induction.
• Compound heterozygous mutations led to embryonic lethality and depletion of MEPs.
• -77-kb enhancer activity was shown to induce burst-forming unit-erythroid through GATA-1 induction.

Conclusions:

• Distinct GATA-2 enhancer elements (+9.5-kb and -77-kb) control specific stages of blood development, with +9.5 essential for HSCs and both required for MEPs.
• Enhancer circuits integrate signaling pathways to orchestrate GATA factor-dependent blood development.
• Findings clarify the functional redundancy and specificity of GATA-2 enhancers in hematopoiesis.